Predict your next investment

HEALTHCARE | Drug Development
pathwaytx.com

See what CB Insights has to offer

Executives

1

Board of Directors

3

Pathway Therapeutics Board of Directors

3 Board of directors

Pathway Therapeutics has 3 board of directors, including Hillary Lewis.

Name

Firm

Work History

Other Seats

Hillary Lewis

My strengths and experience is in leading programmes of change, technology, innovation and business process improvement in large, medium, entrepreneurial and social enterprises. My particular focus has been the airline and travel sector, with over 25 years in senior and strategic roles across Australasia, the Middle East and USA. Success has come from having clarity in vision, strong commercial imperative, attention to detail, and an ability to communicate and engage all involved. This is supported by a strong finance, IT, commercial, strategic and executive background.

Pathway Therapeutics

Joshua Funder

Pathway Therapeutics

Mark Harvey

Mark is an experienced entrepreneur with 23 years experience in the technology sector with a strong emphasis on hardware and software engineering.He joined CM Capital in 2006 and is involved in all aspects of IT and Telecommunication investments. Over the past 16 years Mark has acted in General Management, Chief Executive, and Global Sales/Marketing capacities, with a central theme of building organizations to take technology to the global market.With experience developing, selling and delivering complex systems to over 30 countries and managing globally diverse technology companies Mark has been involved in the many challenges facing entrepreneurs and managers in this sector, including capital raising in several continents. In early 1994 Mark became CEO of a telecom software products company Pacific Star Technologies. Under Mark's guidance PST grew to 100 staff in Australia with major contracts in Europe, Asia, Central America and Australia before concluding a successful trade sale to fast-growing Nasdaq company Claremont in the US in 1997. That led Mark into key senior executive roles in global US organizations, both public and private, including EVP Worldwide Sales for a telecom software organisation which grew sales globally over 100% per annum during his three year tenure in the role. Mark's return to Australia in 2003 was triggered by his recruitment into the role of CEO at satellite modem developer, DSpace. In this role Mark developed the management team and created strong revenue growth through a top tier industry customer list. He transitioned his role to the team upon reaching profitable and cash positive operations in 2006. He then managed a successful trade sale to a large US Corporation. Mesaplexx Pty Ltd &Atilde;&cent;&Acirc;€" (Current)</br> Threatmetrix Inc. &Atilde;&cent;&Acirc;€" (Current)</br> DSpace Pty Ltd &Atilde;&cent;&Acirc;€" (Previously)</br> Datacastle - (Current) BE (Hons I) Electrical Engineering, UNSW</br> Diploma of Company Directorship, AICD &amp; Uni of Sydney Graduate School of Management</br> FAICD, Fellow of the Australian Institute of Company Directors</br> Diploma of Financial Services (Financial Markets), AFMA

Pathway Therapeutics

Name

Hillary Lewis

Joshua Funder

Mark Harvey

Firm

Work History

My strengths and experience is in leading programmes of change, technology, innovation and business process improvement in large, medium, entrepreneurial and social enterprises. My particular focus has been the airline and travel sector, with over 25 years in senior and strategic roles across Australasia, the Middle East and USA. Success has come from having clarity in vision, strong commercial imperative, attention to detail, and an ability to communicate and engage all involved. This is supported by a strong finance, IT, commercial, strategic and executive background.

Mark is an experienced entrepreneur with 23 years experience in the technology sector with a strong emphasis on hardware and software engineering.He joined CM Capital in 2006 and is involved in all aspects of IT and Telecommunication investments. Over the past 16 years Mark has acted in General Management, Chief Executive, and Global Sales/Marketing capacities, with a central theme of building organizations to take technology to the global market.With experience developing, selling and delivering complex systems to over 30 countries and managing globally diverse technology companies Mark has been involved in the many challenges facing entrepreneurs and managers in this sector, including capital raising in several continents. In early 1994 Mark became CEO of a telecom software products company Pacific Star Technologies. Under Mark's guidance PST grew to 100 staff in Australia with major contracts in Europe, Asia, Central America and Australia before concluding a successful trade sale to fast-growing Nasdaq company Claremont in the US in 1997. That led Mark into key senior executive roles in global US organizations, both public and private, including EVP Worldwide Sales for a telecom software organisation which grew sales globally over 100% per annum during his three year tenure in the role. Mark's return to Australia in 2003 was triggered by his recruitment into the role of CEO at satellite modem developer, DSpace. In this role Mark developed the management team and created strong revenue growth through a top tier industry customer list. He transitioned his role to the team upon reaching profitable and cash positive operations in 2006. He then managed a successful trade sale to a large US Corporation. Mesaplexx Pty Ltd &Atilde;&cent;&Acirc;€" (Current)</br> Threatmetrix Inc. &Atilde;&cent;&Acirc;€" (Current)</br> DSpace Pty Ltd &Atilde;&cent;&Acirc;€" (Previously)</br> Datacastle - (Current) BE (Hons I) Electrical Engineering, UNSW</br> Diploma of Company Directorship, AICD &amp; Uni of Sydney Graduate School of Management</br> FAICD, Fellow of the Australian Institute of Company Directors</br> Diploma of Financial Services (Financial Markets), AFMA

Other Seats

Pathway Therapeutics

Pathway Therapeutics

Pathway Therapeutics

Pathway Therapeutics Management Team

1 Team Member

Pathway Therapeutics has 1 executive. Pathway Therapeutics's former Chief Executive Officer, President is Julie M Cherrington.

Name

Work History

Title

Status

Julie M Cherrington

Chief Executive Officer, President

Former

Name

Julie M Cherrington

Work History

Title

Chief Executive Officer, President

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.